Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 7, 2016

View Archived Issues

Gilead opens phase II/III study of fixed-dose combination in young patients with HIV-1 infection

New phase Ib study investigates dantrolene sodium for Wolfram syndrome

Primex Pharmaceuticals submits MAA for ADV-6209

Synthetic Biologics awarded CDC contract for SYN-004

RedHill Biopharma provides update on phase III study of RHB-104

Asceneuron receives grant from MJFF

ICU Medical to acquire Pfizer's Hospira Infusion Systems business

Vaccinex, Merck KGaA form collaboration to evaluate VX15/2503 plus avelumab in NSCLC

Santen, RIKEN and FBRI to develop novel retinal disease treatments

Engility awarded task order by Walter Reed for Chikungunya virus vaccine work

FDA accepts Coherus' BLA submission for pegfilgrastim biosimilar

ZF-AAV constructs enables long-term mutant Huntingtin repression in mice

Promising phase II data presented for E-52862

First patient enrolled in Reata Pharmaceuticals' phase III study of bardoxolone methyl

Boston Therapeutics and Advance Pharmaceutical report topline data from study of BTI-320

University of Ljubljana patents PSMB8 inhibitors

NIH grant supports work at IDRI to develop RNA-based Zika virus vaccine

Akarna Therapeutics discloses FXR agonists

Shanghai Yingli Pharmaceutical describes URAT1 inhibitors

Mironid develops PDE4 activators

Hokkaido University presents oxidative stress-induced cell death inhibitors

AstraZeneca to divest ex-U.S. Rhinocort Aqua rights to Cilag

MonoSol Rx and Lupin to develop pediatric products utilizing PharmFilm technology

EMA grants orphan drug designation to Videregen's replacement trachea product

TRPM8 antagonist attenuates oxaliplatin-induced cold allodynia in vivo

GSK makes success payment to Cancer Research Technology and University of Manchester

Teva to commercialize two Celltrion biosimilar candidates in U.S. and Canada

NIH awards support research on the peripheral nervous system

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors
BioWorld Science
Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...